CIBC Bancorp USA’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$109K Buy
18,840
+7,770
+70% +$56.8K ﹤0.01% 2085
2026
Q2
$93.9K Buy
11,070
+674
+6% +$4.48K ﹤0.01% 1858
2026
Q1
$56.7K Buy
+10,396
New +$58.3K ﹤0.01% 1714
2025
Q3
$145K Buy
+18,748
New +$146K ﹤0.01% 1313

Other funds holding TDOC

CIBC Bancorp USA's TDOC Position: Q3 2026 in Review

CIBC Bancorp USA increased its Teladoc Health (TDOC) stake by 70% in Q3 2026, buying an estimated $56.8K and bringing the position to 18,840 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2085.

CIBC Bancorp USA first reported a position in TDOC in Q3 2025 and has held it in 4 quarters since. The position peaked at $145K in Q3 2025. 324 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • CIBC Bancorp USA held 18,840 shares of Teladoc Health worth $109K as of Q3 2026.
  • CIBC Bancorp USA bought 7,770 Teladoc Health shares in Q3 2026, an estimated $56.8K.
  • Teladoc Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2085 holding.
  • CIBC Bancorp USA first reported a position in Teladoc Health in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Teladoc Health position peaked at $145K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.